CD274 and non-small cell lung carcinoma: Consolidative PD-L1 inhibition after concurrent chemo-radiation significantly improved survival in unresectable stage III NSCLC in the PACIFIC study, and this approach has become the standard care of locally advanced NSCLC (298).